Home
Products
COVID-19 POCT
Antigen Rapid Test
VOC-based POCT
Women's Health
Pneumonia
Ainos Pen
AI Nose
Technology
AI Nose
Low-dose interferon
Synthetic RNA
Support
About Us
News
Investors
English
繁體中文
日本語
News Releases
Search by year or by keyword :
Search
Date
Title
2025-12-16
Ainos to Relocate U.S. Headquarters to Houston, Texas; Forms ScentAI Inc.
2025-10-14
Ainos and NEXCOM Partner to Expand AI Nose Ecosystem into Industrial Edge AI
2025-09-30
Ainos Expands Global IP Portfolio to 123 Patents with Seven New AI Nose Patents
2025-09-16
Ainos and Topco Sign Distribution Agreement to Accelerate Global Expansion of AI Nose
2025-09-08
Ainos to Showcase AI Nose at SEMICON Taiwan 2025
2025-08-14
Ainos Debuts World's First Patented AI Nose Device, Bringing Machine Scent Intelligence to Industry and Healthcare
2025-08-06
Ainos Secures $2.1 Million Order With ASE for First Deployment of AI Nose in Semiconductor Manufacturing Setting
2025-08-04
Ainos Receives TFDA Approval to Initiate Clinical Study of VELDONA for Primary Sjögren's Syndrome
2025-07-22
Ainos and ugo Launch World's First AI Nose-Enabled Service Robot Pilots in Seven Sites Across Japan's Industrial Sector
2025-07-07
Ainos and Solomon Partner to Bring SmellTech Across Asia's Industrial Landscape
«
1
2
3
4
5
6
7
8
»
CONTACT US
United States:
3050 Post Oak Blvd, Suite 510-T80, Houston, TX 77056
+1 (281) 898-6586
Taiwan:
10F-2, No. 66, Shengyi 5th Rd., Zhubei City, Hsinchu County 302 , Taiwan (R.O.C.)
+886 (0)3-550-5199
COMPANY
Products
AI Nose
Low-Dose Oral Interferon
Synthetic RNA
News
Privacy policy
INVESTORS
Overview
Stock Info
IR News
Governance
Financials
Alerts
OUR AGENTS
INABATA & CO., LTD.
TAIWAN ORIACT CO., LTD.
Copyright © 2023 Ainos Inc. All rights reserved.